Novo Nordisk: The Illusion Of Cheap [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO's revenue growth is decelerating, with Q4 growth under 5% and gross margin down over 300 bps YoY amid intensifying competition from Eli Lilly. Regulatory risks have increased, with two recent FDA warnings and the threat of cheap semaglutide generics undermining future pricing power. Despite headwinds, NVO's strong balance sheet and near-5% dividend yield offer appeal to income-focused investors, but growth outlook remains challenged. Getty Images My previous cautious article about Novo Nordisk ( NVO ) as of December 2025 aged quite well because the stock currently trades approximately 20% cheaper than it did back then. Of course, after such a notable share price decline, valuation of This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rece
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares [Yahoo! Finance]Yahoo! Finance
- This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock [Yahoo! Finance]Yahoo! Finance
- HSBC downgrades Eli Lilly, says shares are ‘priced to perfection' [Yahoo! Finance]Yahoo! Finance
- Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S Investigated by the Portnoy Law FirmGlobeNewswire
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/17/26 - Form 6-K
- 3/9/26 - Form 6-K
- 3/2/26 - Form 6-K
- NVO's page on the SEC website